Abstract Background Adjuvant endocrine therapy (AET) reduces the risk of breast cancer recurrence and mortality. However. up to three-quarters of women with breast cancer do not take AET as prescribed. Existing interventions to support adherence to AET have largely been unsuccessful. https://lampsusaes.shop/product-category/lamp-shade/